Skip to main content
. Author manuscript; available in PMC: 2016 Aug 10.
Published in final edited form as: Urolithiasis. 2014 Mar 12;42(3):195–202. doi: 10.1007/s00240-014-0649-0

Fig. 2.

Fig. 2

Fluorescence imaging; Alexa633-labeled atelocollagen (AteroGene™) was revealed between renal cortical injection (c.j.) and renal sub-capsular injection (s.c.) of atelocallagen. Atelocollagen injected in the renal cortex remained at the injection site after 24 h of the treatment, whereas atelocollagen injected at the sub-capsular site was visualized in the renal parenchyma far from the injection site. Image analysis was performed by macro-imaging station, BioView 1000 mounted onto a dark box and using 530/610 nm excitation/emission filters